Stay updated on ESMART: Molecular Stratification Clinical Trial
Sign up to get notified when there's something new on the ESMART: Molecular Stratification Clinical Trial page.

Latest updates to the ESMART: Molecular Stratification Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe revision tag on the page changed from v3.5.3 to v3.5.4, indicating a newer revision of the record.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision label on the page changed from v3.5.2 to v3.5.3. This indicates a new release or update to the page content.SummaryDifference0.0%

- Check32 days agoChange DetectedThe publication listing for a referenced article about fadraciclib in Arm K was updated from an “online ahead of print” citation to a finalized citation with specific month/date details.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check61 days agoChange DetectedAdded a new publication citation to Publications: Rubio-San-Simon A et al., Phase I/II Study of the CDK2/9 Inhibitor Fadraciclib in Children with Advanced Malignancies (Arm K of the AcSe-ESMART Trial), Target Oncol. 2026 Mar 16, DOI: 10.1007/s11523-026-01208-1. Revision: v3.5.0.SummaryDifference0.1%

- Check75 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to ESMART: Molecular Stratification Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ESMART: Molecular Stratification Clinical Trial page.